Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

NCT00556127 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma
POOR PROGNOSIS

Interventions

DRUG: Rituximab
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone
DRUG: Granulocyte-colony-stimulating factor
DRUG: Mitoxantrone
DRUG: Cytarabine ARA-C
DRUG: Dexamethasone
DRUG: Carmustine BCNU
DRUG: Etoposide
DRUG: Melphalan
RADIATION: Radiotherapy
PROCEDURE: PBSC reinfusion

Sponsor

Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie